{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:00:15Z","timestamp":1781650815088,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cerebral toxoplasmosis is a rare but potentially fatal opportunistic infection in non-HIV immunocompromised patients, particularly after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Diagnosis is often delayed due to nonspecific clinical manifestations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      We report a 66-year-old man with myelodysplastic syndrome that had transformed into secondary acute myeloid leukemia. Following remission induction with CPX-351, he underwent allo-HSCT and received ciclosporin A, mycophenolate mofetil, and corticosteroids for graft-versus-host disease prophylaxis. Standard cotrimoxazole prophylaxis was withheld because of hepatic intolerance and thrombocytopenia, and inhaled pentamidine was administered instead. Three months post-transplant, the patient presented with bilateral visual field deficits. Automated perimetry revealed a homonymous inferior quadrantanopia. Brain MRI demonstrated a solitary ring-enhancing lesion in the left optic radiation, and cerebrospinal fluid PCR confirmed\n                      <jats:italic>Toxoplasma gondii<\/jats:italic>\n                      . Treatment with sulfadiazine, pyrimethamine, and folinic acid was initiated, followed by long-term secondary prophylaxis. Despite residual visual impairment, the patient achieved clinical stability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case underscores the diagnostic value of neuro-ophthalmologic examination and early neuroimaging in detecting opportunistic CNS infections. It also highlights the challenges of prophylactic decision-making in immunocompromised patients when cotrimoxazole is contraindicated. Individualized immunosuppressive and prophylactic strategies, along with multidisciplinary care, were key to successful management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-026-00582-1","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:45:26Z","timestamp":1777358726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bilateral visual impairment caused by Toxoplasma gondii encephalitis and ocular GVHD in a patient after allo-HSCT"],"prefix":"10.1186","volume":"16","author":[{"given":"Armin Taghavi","family":"Eraghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dietrich-Ntoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"5","key":"582_CR1","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/S1473-3099(23)00495-4","volume":"24","author":"R Aerts","year":"2024","unstructured":"Aerts R, Maertens J, Bretagne S et al (2024) Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after HSCT (ECIL-9). Lancet Infect Dis 24(5):e291\u2013e306. https:\/\/doi.org\/10.1016\/S1473-3099(23)00495-4","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"582_CR2","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.bbmt.2019.07.035","volume":"25","author":"C Robin","year":"2019","unstructured":"Robin C, Leducq V, Dhedin N et al (2019) Toxoplasmosis as an early complication of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl 25(12):2510\u20132513","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"582_CR3","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1086\/317471","volume":"31","author":"R Martino","year":"2000","unstructured":"Martino R, Maertens J, Bretagne S et al (2000) Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 31(5):1188\u20131195","journal-title":"Clin Infect Dis"},{"issue":"12","key":"582_CR4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1469-0691.2008.02091.x","volume":"14","author":"F Derouin","year":"2008","unstructured":"Derouin F, Pelloux H (2008) Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 14(12):1089\u20131101","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"582_CR5","first-page":"421","volume":"27","author":"HT Schwenk","year":"2021","unstructured":"Schwenk HT, Dandoy CE, Rogers K et al (2021) Toxoplasmosis in pediatric HSCT: epidemiology, presentation, treatment, and prevention. Transpl Cell Ther 27(5):421\u2013429","journal-title":"Transpl Cell Ther"},{"issue":"6","key":"582_CR6","first-page":"955","volume":"66","author":"D Kalogeropoulos","year":"2021","unstructured":"Kalogeropoulos D, Sung VC, Paschalis EI et al (2021) Ocular toxoplasmosis: current diagnostic and therapeutic approaches. Surv Ophthalmol 66(6):955\u2013976","journal-title":"Surv Ophthalmol"},{"issue":"25","key":"582_CR7","first-page":"435","volume":"116","author":"U Pleyer","year":"2019","unstructured":"Pleyer U, Gross U, Schl\u00fcter D et al (2019) Toxoplasmosis in Germany. Dtsch Arztebl Int 116(25):435\u2013444","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"582_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/QCO.0000000000000169","volume":"28","author":"K Gajurel","year":"2015","unstructured":"Gajurel K, Dhakal R, Montoya JG (2015) Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review and recommendations. Curr Opin Infect Dis 28(4):283\u2013292","journal-title":"Curr Opin Infect Dis"},{"key":"582_CR9","doi-asserted-by":"crossref","unstructured":"Dietrich-Ntoukas T, Cursiefen C, Westekemper H, Eberwein P, Reinhard T, Bertz H, Nepp J, Lawitschka A, Heiligenhaus A, Seitz B, Messmer EM, Meyer-ter- Vehn T, Basara N, Greinix H, Datiles MB, Lee SJ, Pavletic SZ, Wolff D (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in Chronic GVHD. Cornea;31(3):299\u2013310","DOI":"10.1097\/ICO.0b013e318226bf97"},{"key":"582_CR10","unstructured":"Orefice G, Cret\u00ed A, Bonadies G, Tullio-Cataldo P, Rubino S (1985) Isolated homonymous lateral hemianopsia revealing central nervous system toxoplasmosis as the initial manifestation of AIDS. Metab Pediatr Syst Ophthalmol.16(1\u20132):15\u201318. PMID: 8259069"},{"issue":"1","key":"582_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/0974-620X.94768","volume":"5","author":"N Bonnin","year":"2012","unstructured":"Bonnin N et al (2012) Toxoplasmic pachymeningitis with visual field impairment in a single-eyed patient and a literature review. Oman J Ophthalmol 5(1):46\u201350. https:\/\/doi.org\/10.4103\/0974-620X.94768","journal-title":"Oman J Ophthalmol"},{"key":"582_CR12","doi-asserted-by":"publisher","unstructured":"Girard PM, Landman R, Gaudebout C, PRIO Study Group (1993). Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med;328(21):1514\u20131520. https:\/\/doi.org\/10.1056\/NEJM199305273282102. PMID: 8479488","DOI":"10.1056\/NEJM199305273282102"},{"key":"582_CR13","doi-asserted-by":"publisher","unstructured":"Opravil M, Hirschel B, Lazzarin A et al (1995) Once-weekly administration of dapsone\/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in HIV-infected patients. Clin Infect Dis;20(3):531\u2013541. https:\/\/doi.org\/10.1093\/clinids\/20.3.531. PMID: 7756472","DOI":"10.1093\/clinids\/20.3.531"},{"issue":"RR\u201310","key":"582_CR14","first-page":"1","volume":"49","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","unstructured":"Centers for Disease Control and Prevention (CDC) (2000) Infectious Diseases Society of America (IDSA), and American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 49(RR\u201310):1\u2013128 PMID: 11060606","journal-title":"MMWR Recomm Rep"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-026-00582-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:50:58Z","timestamp":1781650258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-026-00582-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1186\/s12348-026-00582-1","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this single case report, as all clinical data were obtained as part of routine patient care and presented in anonymized form, in accordance with institutional and national ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of this anonymized case report and any accompanying clinical data was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof Dr Uwe Pleyer is an Associate Editor for the journal. However, he was not involved in the editorial handling or decision-making process for this manuscript. The rest of the authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}